FDA warning that high strength doses of Zocor, generic Zocor (Simvastatin), and Vytorin increase the risk of rhabdomyolysis
Dateline: March 19, 2010
Contact Name: David Rosenberg, Attorney at Law
Contact Phone: (800) 461-4140
Email: rosenberg@hhrlaw.com
Based on data from a large clinical trial, the U.S. Food and Drug Administration (FDA) is informing the public about an increased risk of muscle injury in patients taking the maximum approved dosage of Zocor (simvastatin 80mg). The data under review by the FDA is from the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH).
Myopathy, a muscle injury, is a known side effect with all statin medications. Myopathy symptoms include:
The higher the dose of statin, the greater the risk of developing myopathy. The most severe form of myopathy is called rhabdomyolysis, which occurs when a protein (myoglobin) is released. Myoglobin is released as muscle fibers break down and it can cause kidney damage. In fact, rhabdomyolysis can cause such serious kidney damage that patients may develop kidney failure, which can be fatal.
More Information About High Dose Zocor
FDA Safety Announcement
Simvistatin (Marketed as Zocor) Information
About Handler Henning & Rosenberg, LLP:
Since 1922 the personal injury attorneys at Handler Henning & Rosenberg, LLP have been helping seriously injured people in Pennsylvania. For over 87 years, Handler Henning & Rosenberg, LLP has been representing injured people against powerful insurance companies and corporations.
Handler Henning & Rosenberg represents many plaintiffs throughout the state of Pennsylvania with similar cases against drug manufacturers. For more information please visit the Side Effects page of our website.
Back to the Latest News & Press Releases directory
EDITOR’S NOTE:
If you or a family member have suffered Myopathy or Rhabdomyolysis after taking High Dose Zocor they can call Attorney David Rosenberg at the Law Offices of Handler Henning & Rosenberg, LLP at (800) 461-4140.
Interviews by the press can also be arranged by calling (800) 422-2224 or e-mailing us at: rosenberg@hhrlaw.com
